Jamison Pike

959 total citations
33 papers, 604 citations indexed

About

Jamison Pike is a scholar working on Epidemiology, Health and Infectious Diseases. According to data from OpenAlex, Jamison Pike has authored 33 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 14 papers in Health and 10 papers in Infectious Diseases. Recurrent topics in Jamison Pike's work include Vaccine Coverage and Hesitancy (14 papers), COVID-19 epidemiological studies (7 papers) and Influenza Virus Research Studies (6 papers). Jamison Pike is often cited by papers focused on Vaccine Coverage and Hesitancy (14 papers), COVID-19 epidemiological studies (7 papers) and Influenza Virus Research Studies (6 papers). Jamison Pike collaborates with scholars based in United States, Denmark and Japan. Jamison Pike's co-authors include Scott D. Grosse, Peter Daszak, David Finnoff, Sarah Elwood, Tiffany L. Bogich, Andrew J. Leidner, Gabrielle F. Miller, J. Mick Tilford, Paul A. Gastañaduy and Lisa A. Prosser and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PEDIATRICS and Clinical Infectious Diseases.

In The Last Decade

Jamison Pike

31 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jamison Pike United States	11	164	151	132	106	96	33	604
Fátima Coronado United States	17	203 1.2×	87 0.6×	135 1.0×	346 3.3×	80 0.8×	50	875
Srikanta Kanungo India	14	200 1.2×	85 0.6×	152 1.2×	70 0.7×	91 0.9×	102	648
Emilio Dirlikov United States	13	136 0.8×	48 0.3×	279 2.1×	82 0.8×	87 0.9×	28	611
Malizgani Mhango Zimbabwe	12	70 0.4×	86 0.6×	171 1.3×	136 1.3×	36 0.4×	19	534
Matthew Tunis Canada	13	241 1.5×	38 0.3×	156 1.2×	92 0.9×	183 1.9×	42	718
Trude Arnesen Norway	17	236 1.4×	337 2.2×	223 1.7×	258 2.4×	112 1.2×	33	940
Ram Koppaka United States	9	120 0.7×	38 0.3×	99 0.8×	97 0.9×	183 1.9×	16	457
Stella Talic Australia	8	59 0.4×	121 0.8×	155 1.2×	58 0.5×	73 0.8×	23	599
David Bui United States	11	64 0.4×	57 0.4×	88 0.7×	98 0.9×	63 0.7×	34	484
Sujan Babu Marahatta Nepal	16	134 0.8×	73 0.5×	246 1.9×	95 0.9×	49 0.5×	63	808

Countries citing papers authored by Jamison Pike

Since Specialization

Citations

This map shows the geographic impact of Jamison Pike's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamison Pike with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamison Pike more than expected).

Fields of papers citing papers by Jamison Pike

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jamison Pike. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamison Pike. The network helps show where Jamison Pike may publish in the future.

Co-authorship network of co-authors of Jamison Pike

This figure shows the co-authorship network connecting the top 25 collaborators of Jamison Pike. A scholar is included among the top collaborators of Jamison Pike based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamison Pike. Jamison Pike is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rose, Angela M., Christopher J. Cadham, Acham Gebremariam, et al.. (2025). Health Preferences in Transition: Differences from Pandemic to Post-Pandemic in Valuation of COVID-19 and RSV Illness in Children and Adults. Children. 12(2). 181–181. 3 indexed citations

Hutton, David W., Lisa A. Prosser, Angela Rose, et al.. (2024). Cost-Effectiveness of Maternal Vaccination to Prevent Respiratory Syncytial Virus Illness. PEDIATRICS. 154(6). 10 indexed citations

Hutton, David W., Lisa A. Prosser, Angela M. Rose, et al.. (2024). Cost-effectiveness of vaccinating adults aged 60 years and older against respiratory syncytial virus. Vaccine. 42(24). 126294–126294. 9 indexed citations

Pike, Jamison, et al.. (2024). 2022 Polio outbreak, Rockland County, NY: Cost evaluation of strategies to prevent future outbreaks of vaccine-preventable diseases. Vaccine. 42(7). 1793–1798.

Hutton, David W., Lisa A. Prosser, Angela Rose, et al.. (2024). Cost-Effectiveness of Nirsevimab for Respiratory Syncytial Virus in Infants and Young Children. PEDIATRICS. 154(6). 13 indexed citations

Prosser, Lisa A., Abram L. Wagner, Eve Wittenberg, et al.. (2023). A Discrete Choice Analysis Comparing COVID-19 Vaccination Decisions for Children and Adults. JAMA Network Open. 6(1). e2253582–e2253582. 10 indexed citations

Gidengil, Courtney A., Jefferson M. Jones, Katherine E. Fleming-Dutra, et al.. (2023). 1633. Willingness to receive maternal RSV vaccine and infant monoclonal RSV antibody. Open Forum Infectious Diseases. 10(Supplement_2). 2 indexed citations

Leidner, Andrew J., Tara C. Anderson, Ismael R. Ortega‐Sanchez, et al.. (2022). Cost-Effectiveness Analysis of Vaccination With Recombinant Zoster Vaccine Among Hematopoietic Cell Transplant Recipients and Persons With Other Immunocompromising Conditions Aged 19 to 49 Years. Value in Health. 26(2). 204–215. 4 indexed citations

Yarnoff, Benjamin, et al.. (2022). Assessment of the Costs of Implementing COVID-19 Vaccination Clinics in 34 Sites, United States, March 2021. Journal of Public Health Management and Practice. 28(6). 624–630. 1 indexed citations

10.

Board, Amy, Sun-Kyung Kim, Joo‐Hyun Park, et al.. (2022). Risk factors for COVID-19 among persons with substance use disorder (PWSUD) with hospital visits – United States, April 2020–December 2020. Drug and Alcohol Dependence. 232. 109297–109297. 12 indexed citations

11.

Hutton, David W., Jeffrey S. McCullough, Lisa A. Prosser, et al.. (2021). Costs implications of pneumococcal vaccination of adults aged 30–60 with a recent diagnosis of diabetes. Vaccine. 39(8). 1333–1338. 1 indexed citations

12.

Pike, Jamison, Jason F. Shogren, David Aadland, et al.. (2020). Catastrophic Risk: Waking Up to the Reality of a Pandemic?. EcoHealth. 17(2). 217–221. 8 indexed citations

13.

Pike, Jamison, et al.. (2019). 2016–2017 Arkansas mumps outbreak in a close-knit community: Assessment of the economic impact and response strategies. Vaccine. 38(6). 1481–1485. 5 indexed citations

14.

Goodman, Robert M., Carolyn B. Bridges, David W. Kim, et al.. (2019). Billing and payment of commercial and Medicaid health plan adult vaccination claims in Michigan since the Affordable Care Act. Vaccine. 37(45). 6803–6813. 1 indexed citations

15.

Grosse, Scott D., et al.. (2019). Quantifying Family Spillover Effects in Economic Evaluations: Measurement and Valuation of Informal Care Time. PharmacoEconomics. 37(4). 461–473. 48 indexed citations

16.

Pike, Jamison, Sheryl Schwartz, Meagan Kay, et al.. (2019). Cost of Responding to the 2017 University of Washington Mumps Outbreak: A Prospective Analysis. Journal of Public Health Management and Practice. 26(2). 116–123. 4 indexed citations

17.

Pike, Jamison & Scott D. Grosse. (2018). Friction Cost Estimates of Productivity Costs in Cost-of-Illness Studies in Comparison with Human Capital Estimates: A Review. Applied Health Economics and Health Policy. 16(6). 765–778. 131 indexed citations

18.

Carias, Cristina, Harrell W. Chesson, Scott D. Grosse, et al.. (2018). Recommendations of the Second Panel on Cost Effectiveness in Health and Medicine: A Reference, Not a Rule Book. American Journal of Preventive Medicine. 54(4). 600–602. 33 indexed citations

19.

Pike, Jamison, Andrew J. Leidner, Jessica R. MacNeil, & Amanda Cohn. (2018). Review of the economic evidence presented to the United States Advisory Committee on Immunization Practices, 2012–2016. Vaccine. 37(1). 7–10. 4 indexed citations

20.

Pike, Jamison, et al.. (2017). Cost of a measles outbreak in a remote island economy: 2014 Federated States of Micronesia measles outbreak. Vaccine. 35(43). 5905–5911. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact